Application 214095
- Type
- ANDA
- Sponsor
- APOTEX
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE | EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE | TABLET;ORAL | 200MG;EQ 25MG BASE;EQ 25MG BASE | No | No |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 84897 | ORIG | 2026-02-03 |